Last update :
14/06/2024
Various   Octreotide acetate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Akroken Mexico
Badastin Ecuador
Bendatreotid Egypt
Cryostatin Mexico
Gasterina Argentina, Chile
Jintrotide Peru
Longastatina Italy
Nomactril Mexico
Ocphyl Canada
Octate India
Octide India
Octotide Ecuador
Octreotid Germany
Octreotida Spain
Octreotide Canada, Great Britain, United States of America
Octride Colombia, Ecuador
Samilstin Italy
Sandostatin Argentina, Australia, Austria, Brazil, Canada, Chile, Denmark, Ecuador, Finland, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Luxembourg, Malaysia, New Zealand, Norway, Poland, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America
Sandostatina Italy, Portugal
Sandostatine Belgium, France, Morocco, Netherlands, Portugal
Secrestat Colombia
Siroctid Belgium
Compatibility   Injection   Compatibility : Octreotide acetate              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
Compound Solvent References
Unspecified incompatibility Incompatible
Injection Octreotide acetate
Parenteral nutrition (with lipids) 4086
Compatible
Injection Octreotide acetate 0,5 mg/ml
Ringer’s lactate solution 4603
Compatible
Injection Octreotide acetate 0.00045 mg/ml
Parenteral nutrition (with lipids) 466
Compatible
Injection Octreotide acetate 0.5 mg/ml
Injection Amoxicillin sodium / clavulanic acid 100/10 mg/ml
3824
Compatible
Injection Octreotide acetate 0.025 mg/ml
Parenteral nutrition (with lipids) 3948
Compatible
Injection Octreotide acetate 10 mg/ml
Parenteral nutrition (with lipids) 1415
Compatible
Injection Octreotide acetate 0.004 mg/ml
Injection Cefiderocol sulfate tosylate 20 mg/mL
NaCl 0,9% or Glucose 5% 4528
Compatible
Injection Octreotide acetate 0.004 mg/ml
Injection Ceftolozane / tazobactam 10/5 mg/ml
NaCl 0,9% or Glucose 5% 3828
Compatible
Injection Octreotide acetate 0,075 mg/ml
Injection Diamorphine hydrochloride 25 mg/ml
Water for Injection 2404
Compatible
Injection Octreotide acetate 0,0375 mg/ml
Injection Diamorphine hydrochloride 12,5 mg/ml
Water for Injection 2404
Compatible
Injection Octreotide acetate 0,1125 mg/ml
Injection Diamorphine hydrochloride 12,5 mg/ml
Water for Injection 2404
Compatible
Injection Octreotide acetate 0,075 mg/ml
Injection Diamorphine hydrochloride 12,5 mg/ml
Water for Injection 2404
Compatible
Injection Octreotide acetate 0,075 mg/ml
Injection Diamorphine hydrochloride 6,25 mg/ml
Water for Injection 2404
Compatible
Injection Octreotide acetate 0,1125 mg/ml
Injection Diamorphine hydrochloride 6,25 mg/ml
Water for Injection 2404
Compatible
Injection Octreotide acetate 0,0375 mg/ml
Injection Diamorphine hydrochloride 6,25 mg/ml
Water for Injection 2404
Precipitation after 1 hour Incompatible
Injection Octreotide acetate
Injection Dimenhydrinate
2087
Compatible
Injection Octreotide acetate 0.004 mg/ml
Injection Fosfomycin 30 mg/ml
NaCl 0,9% or Glucose 5% 4055
Compatible
Injection Octreotide acetate 0,01 & 0,02 mg/ml
Injection Insulin aspart 1 UI/ml
NaCl 0,9% or Glucose 5% 1508
Compatible
Injection Octreotide acetate 0.004 mg/ml
Injection Isavuconazonium sulfate 1.5 mg/ml
NaCl 0,9% or Glucose 5% 3829
Compatible
Injection Octreotide acetate 0.025 mg/ml
Parenteral nutrition (binary mixture) 3948
Compatible
Injection Octreotide acetate 0,004 mg/ml
Injection Eravacycline 0,6 mg/ml
Sodium chloride 0,9% 4434
Precipitation after 4 hours Incompatible
Injection Octreotide acetate 0.005 mg/ml
Injection Micafungin 1.5 mg/ml
Sodium chloride 0,9% 2108
Compatible
Injection Octreotide acetate 0.5 mg/ml
Injection Naloxone hydrochloride 0.4 mg/ml
None 3408
Compatible
Injection Octreotide acetate < 0.004 mg/ml
Injection Pantoprazole sodium > 0.5 mg/ml
Sodium chloride 0,9% 1902
Compatible
Injection Octreotide acetate < 0.0015 mg/ml
Injection Pantoprazole sodium < 0.8 mg/ml
Sodium chloride 0,9% 1902
Immediate precipitation Incompatible
Injection Octreotide acetate
Injection Pantoprazole sodium
2090
Color change Incompatible
Injection Octreotide acetate > 0.004 mg/ml
Injection Pantoprazole sodium > 0.5 mg/ml
Sodium chloride 0,9% 1902
Compatible
Injection Octreotide acetate 0.5 mg/ml
Injection Paracetamol 10 mg/ml
4742
Compatible
Injection Octreotide acetate 0.004 mg/ml
Injection Plazomicin sulfate 24 mg/ml
Sodium chloride 0,9% 4145
Compatible
Injection Octreotide acetate 0,030 mg/ml
Injection Remdesivir 1 mg/ml
Sodium chloride 0,9% 4768
Immediate precipitation Incompatible
Injection Octreotide acetate 0,5 mg/ml
Injection Salbutamol sulfate 1 mg/ml
None 3216
Compatible
Injection Octreotide acetate 0,004 mg/ml
Injection Sulbactam/durlobactam 15/15 mg/ml
Sodium chloride 0,9% 4801
Immediate precipitation Incompatible
Injection Octreotide acetate 0.5 mg/ml
Injection Thiopental sodium 25 mg/ml
Sodium chloride 0,9% 3767
Compatible
Injection Octreotide acetate 0.010 mg/ml
Parenteral nutrition (binary mixture) 301

  Mentions Légales